NCT00366093View on ClinicalTrials.gov

Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/Menopause

PHASE3CompletedINTERVENTIONAL

Enrollment

410

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions

Insomnia

Interventions

DRUG

Eszopiclone

eszopiclone 3 mg

DRUG

Placebo

placebo tablet

Trial Locations (51)

Unknown

Mobile

San Diego

Denver

Newington

Aventura

Clearwater

Fort Meyers

Gainesville

Melbourne

Miami

Naples

New Port Richey

Pembroke Pines

Tampa

West Palm Beach

Atlanta

Savannah

Arlington Heights

Champaign

Chicago

Lexington

Louisville

Boston

Brockton

Ann Arbor

St Louis

Lincoln

Reno

Rochester

Cary

Raleigh

Winston-Salem

Cleveland

Dayton

Mentor

Oklahoma City

Medford

Erie

Philadelphia

Pittsburgh

Warwick

Columbia

Cordova

Houston

Irving

Sandy City

Richmond

Renton

Seatle

Spokane

Tacoma

All Listed Sponsors

lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT00366093 - Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/Menopause | Biotech Hunter | Biotech Hunter